Related Experiment Videos
Innovative antineoplastic agents
1Experimental Therapeutics Program, Cleveland Clinic Cancer Center, Cleveland, Ohio, USA.
Abstract:
Cancer treatment options are changing as a result of extensive research efforts. New drugs and drug combinations proceed through specific phases of clinical research leading to possible Food and Drug Administration review and approval. Phase I, II, III, and IV clinical trials have detailed enrollment criteria and treatment plans designed to determine research objectives. These objectives can include reduction of toxicity, increased efficacy, and improved quality of life. Liposomal drug formulations, monoclonal antibody therapies, and cytoprotective agents are some of the new treatment approaches that have shown promise in clinical trials. This article reviews the clinical trial process, several innovative therapies, and the nursing responsibilities associated with caring for the patient with cancer.
Insights
Cancer research is advancing new treatments like liposomal drugs and monoclonal antibodies through rigorous clinical trials (Phase I-IV). This review covers trial processes, innovative therapies, and essential nursing care for cancer patients.
Area of Science:
- Oncology
- Clinical Pharmacology
- Cancer Nursing
Background:
- Extensive research is driving significant changes in cancer treatment modalities.
- The development pipeline for novel cancer drugs involves distinct phases of clinical research and regulatory review.
Purpose of the Study:
- To review the clinical trial process for new cancer therapies.
- To discuss innovative treatment approaches showing promise in clinical trials.
- To outline nursing responsibilities in managing cancer patients undergoing novel treatments.
Main Methods:
- Review of clinical trial phases (I, II, III, IV) including enrollment criteria and treatment objectives.
- Identification and discussion of emerging cancer therapies such as liposomal drug formulations, monoclonal antibodies, and cytoprotective agents.
- Examination of nursing roles in patient care throughout innovative cancer treatment protocols.
Main Results:
- Clinical trials are essential for evaluating new cancer drugs, focusing on toxicity reduction, efficacy enhancement, and quality of life improvement.
- Innovative therapies including liposomal formulations and monoclonal antibodies demonstrate potential in clinical settings.
- Defined nursing responsibilities are critical for supporting patients during complex cancer treatment regimens.
Conclusions:
- The landscape of cancer treatment is evolving, with clinical trials playing a pivotal role in advancing therapeutic options.
- Innovative treatments are emerging from clinical research, offering new hope for cancer patients.
- Nurses are integral to the successful implementation of novel cancer therapies and comprehensive patient care.